Literature DB >> 7869034

Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line.

H Lee1, M Arsura, M Wu, M Duyao, A J Buckler, G E Sonenshein.   

Abstract

Treatment of immature murine B lymphocytes with an antiserum against their surface immunoglobulin (sIg)M results in cell death via apoptosis. The WEHI 231 B cell line (IgM, kappa) has been used extensively as a model for this anti-Ig receptor-mediated apoptosis. Anti-sIg treatment of WEHI 231 cells causes an early, transient increase in the levels of c-myc messenger RNA and gene transcription, followed by a rapid decline below control values. Given the evidence for a role of the c-myc gene in promoting apoptosis, we have characterized the nature and kinetics of changes in the binding of Rel-related factors, which modulate c-myc promoter activity. In exponentially growing WEHI 231 cells, multiple Rel-related binding activities were detectable. The major binding species was identified as p50/c-Rel heterodimers; only minor amounts of nuclear factor kappa B (NF-kappa B) (p50/p65) were detectable. Cotransfection of an inhibitor of NF-kappa B (I kappa B)-alpha expression vector reduced c-myc-promoter/upstream/exon1-CAT reporter construct activity, indicating the role of Rel factor binding in c-myc basal expression in these cells. Treatment with anti-sIg resulted in a rapid transient increase in the rate of c-myc gene transcription and in the binding of Rel factors. At later times, formation of p50 homodimer complexes occurred. In cotransfection analysis, p65 and c-Rel expression potently and modestly transactivated the c-myc promoter, respectively, whereas, overexpression of the p50 subunit caused a significant drop in its activity. The role of activation of Rel-family binding was demonstrated directly upon addition of the antioxidant pyrrolidinedithiocarbamate, which inhibited the anti-sIg-mediated activation of the endogenous c-myc gene. Similarly, induction after anti-sIg treatment of a transfected c-myc promoter was abrogated upon cotransfection of an I kappa B-alpha expression vector. These results implicate the Rel-family in Ig receptor-mediated signals controlling the activation of c-myc gene transcription in WEHI 231 cells, and suggest a role for this family in apoptosis of this line, which is mediated through a c-myc signaling pathway.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7869034      PMCID: PMC2191927          DOI: 10.1084/jem.181.3.1169

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  43 in total

1.  Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures.

Authors:  C A Smith; G T Williams; R Kingston; E J Jenkinson; J J Owen
Journal:  Nature       Date:  1989-01-12       Impact factor: 49.962

2.  Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65.

Authors:  R M Schmid; N D Perkins; C S Duckett; P C Andrews; G J Nabel
Journal:  Nature       Date:  1991-08-22       Impact factor: 49.962

Review 3.  Studies of surface immunoglobulin-dependent B cell activation.

Authors:  J G Monroe; V L Seyfert
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

4.  Transcriptional and posttranscriptional control of c-myc gene expression in WEHI 231 cells.

Authors:  R A Levine; J E McCormack; A Buckler; G E Sonenshein
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

5.  DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide.

Authors:  G P Nolan; S Ghosh; H C Liou; P Tempst; D Baltimore
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

6.  Changes in phosphorylation of myc oncogene and RB antioncogene protein products during growth arrest of the murine lymphoma WEHI 231 cell line.

Authors:  S Maheswaran; J E McCormack; G E Sonenshein
Journal:  Oncogene       Date:  1991-11       Impact factor: 9.867

7.  B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50.

Authors:  A Neri; C C Chang; L Lombardi; M Salina; P Corradini; A T Maiolo; R S Chaganti; R Dalla-Favera
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

8.  Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.

Authors:  D S Askew; R A Ashmun; B C Simmons; J L Cleveland
Journal:  Oncogene       Date:  1991-10       Impact factor: 9.867

9.  NF-kappa B contacts DNA by a heterodimer of the p50 and p65 subunit.

Authors:  M B Urban; R Schreck; P A Baeuerle
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

10.  The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B.

Authors:  M L Schmitz; P A Baeuerle
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  36 in total

1.  Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes.

Authors:  Hajir Dadgostar; Brian Zarnegar; Alexander Hoffmann; Xiao-Feng Qin; Uyen Truong; Govinda Rao; David Baltimore; Genhong Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

Review 2.  Roles of the NF-kappaB pathway in lymphocyte development and function.

Authors:  Steve Gerondakis; Ulrich Siebenlist
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

3.  A critical role of TAK1 in B-cell receptor-mediated nuclear factor kappaB activation.

Authors:  James Schuman; Yuhong Chen; Andrew Podd; Mei Yu; Hong-Hsing Liu; Renren Wen; Zhijian J Chen; Demin Wang
Journal:  Blood       Date:  2009-02-05       Impact factor: 22.113

4.  Biological effects of c-Mer receptor tyrosine kinase in hematopoietic cells depend on the Grb2 binding site in the receptor and activation of NF-kappaB.

Authors:  M M Georgescu; K H Kirsch; T Shishido; C Zong; H Hanafusa
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

5.  Inhibition of c-myc expression induces apoptosis of WEHI 231 murine B cells.

Authors:  M Wu; M Arsura; R E Bellas; M J FitzGerald; H Lee; S L Schauer; D H Sherr; G E Sonenshein
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

6.  c-Rel arrests the proliferation of HeLa cells and affects critical regulators of the G1/S-phase transition.

Authors:  J Bash; W X Zong; C Gélinas
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

7.  Kaposi's sarcoma-associated herpesvirus oncoprotein K13 protects against B cell receptor-induced growth arrest and apoptosis through NF-κB activation.

Authors:  Ciaren Graham; Hittu Matta; Yanqiang Yang; Han Yi; Yulan Suo; Bhairavi Tolani; Preet M Chaudhary
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

8.  Transitional B cells exhibit a B cell receptor-specific nuclear defect in gene transcription.

Authors:  Sarah F Andrews; David J Rawlings
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

9.  Reduced c-myc expression levels limit follicular mature B cell cycling in response to TLR signals.

Authors:  Almut Meyer-Bahlburg; Ashok D Bandaranayake; Sarah F Andrews; David J Rawlings
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

10.  NF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphoma.

Authors:  Seong-Su Han; Hwakyung Yun; Dong-Ju Son; Van S Tompkins; Liangping Peng; Seung-Tae Chung; Joong-Su Kim; Eun-Sung Park; Siegfried Janz
Journal:  Mol Cancer       Date:  2010-04-30       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.